Home
Mail
News
Finance
Sports
Entertainment
Search
Mobile
More...
Yahoo Finance
Search
Skip to Navigation
Skip to Main Content
Skip to Related Content
Sign in
Mail
Sign in
to view your mail
Watchlists
My Portfolio
Markets
News
Videos
Yahoo Finance Plus
Screeners
Personal Finance
Crypto
Sectors
Contact Us
Advertisement
U.S. markets open in 6 hours 35 minutes
S&P Futures
5,208.75
-6.00
(-0.12%)
Dow Futures
39,213.00
-10.00
(-0.03%)
Nasdaq Futures
18,189.00
-42.50
(-0.23%)
Russell 2000 Futures
2,047.10
-2.70
(-0.13%)
Crude Oil
82.49
-0.23
(-0.28%)
Gold
2,158.90
-5.40
(-0.25%)
Neurocrine Biosciences, Inc. (NBIX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
Visitors trend
2W
10W
9M
139.44
+0.34
(+0.24%)
At close: 04:00PM EDT
139.51
+0.07
(+0.05%)
After hours:
07:15PM EDT
Summary
Company Insights
Chart
Conversations
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
Advertisement
Show
:
Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
Subscribe to Yahoo Finance Plus Essential to download historical data
Download
Income Statement
Expand All
All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Learn more
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,887,100
1,887,100
1,488,700
1,133,500
1,045,900
Cost of Revenue
39,700
39,700
23,200
14,300
10,100
Gross Profit
1,847,400
1,847,400
1,465,500
1,119,200
1,035,800
Operating Expense
1,452,600
1,452,600
1,216,500
911,400
708,300
Operating Income
394,800
394,800
249,000
207,800
327,500
Net Non Operating Interest Income Expense
-4,600
-4,600
-7,100
-25,800
-32,800
Other Income Expense
-58,100
-58,100
-28,000
-80,600
-188,000
Pretax Income
332,100
332,100
213,900
101,400
106,700
Tax Provision
82,400
82,400
59,400
11,800
-300,600
Net Income Common Stockholders
249,700
249,700
154,500
89,600
407,300
Diluted NI Available to Com Stockholders
249,700
249,700
154,500
89,600
407,300
Basic EPS
1.97
-
1.61
0.95
4.38
Diluted EPS
1.90
-
1.56
0.92
4.16
Basic Average Shares
97,225
-
95,800
94,600
93,100
Diluted Average Shares
100,625
-
98,900
97,900
97,800
Total Operating Income as Reported
250,900
250,900
249,000
102,500
163,000
Total Expenses
1,492,300
1,492,300
1,239,700
925,700
718,400
Net Income from Continuing & Discontinued Operation
249,700
249,700
154,500
89,600
407,300
Normalized Income
293,384
293,384
174,724
160,821
544,540
Interest Expense
4,600
4,600
7,100
25,800
32,800
Net Interest Income
-4,600
-4,600
-7,100
-25,800
-32,800
EBIT
336,700
336,700
221,000
127,200
139,500
EBITDA
358,000
358,000
236,600
138,100
148,100
Reconciled Cost of Revenue
39,700
39,700
23,200
14,300
10,100
Reconciled Depreciation
21,300
21,300
15,600
10,900
8,600
Net Income from Continuing Operation Net Minority Interest
249,700
249,700
154,500
89,600
407,300
Total Unusual Items Excluding Goodwill
-58,100
-58,100
-28,000
-80,600
-188,000
Total Unusual Items
-58,100
-58,100
-28,000
-80,600
-188,000
Normalized EBITDA
416,100
416,100
264,600
218,700
336,100
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-14,416
-14,416
-7,776
-9,379
-50,760
Yahoo Finance Plus Essential access required.
Learn more
Advertisement
Advertisement
Data Disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Your Privacy Choices
About Our Ads
Sitemap
© 2024 Yahoo. All rights reserved.